ArticleJournal of hematology & oncology2021
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer.
Apostolia-Maria Tsimberidou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it